Etanercept responsive acrodermatitis continua of Hallopeau: is a pattern developing?

Author(s): Bonish B, Rashid RM, Swan J

Affiliation(s): Department of Dermatology, Loyola Medical Center, Maywood, IL 60153, USA.

Publication date & source: 2006-10, J Drugs Dermatol., 5(9):903-4.

Publication type: Case Reports

Acrodermatitis continua of Hallopeau (ACH) is a rare disease. Little is known about its etiology or relative effectiveness of the various therapeutic approaches. However, in the literature a pattern seems to be developing on successfully treated patients using biologic therapies. Here, we further emphasize the potential breakthrough presented by the novel immune based therapies. This report consists of a case of etanercept responsive ACH along with a brief review of the literature.